USDA Behavior, Motivation & Nutrition Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-05-31

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will be a cross-sectional study. The primary aim of this study is to compare the relationship between neurological function, metabolic measures and health-related behaviors between normal weight and overweight/obese perimenopausal women.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Motivations for Weight Loss

NCT00011115

Obesity

COMPLETED NA

Behavioral Strategies for Weight Management

NCT00575731

Obesity

COMPLETED NA

Recruiting and Retaining Young Adults in Behavioral Weight Loss Treatment

NCT01889082

Obesity

COMPLETED NA

Effects of Inhibitory Control Training in Eating Behaviors

NCT03599115

Overweight and Obesity

COMPLETED NA

Effectiveness of Behavioral Treatments for Obesity and Major Depression in Women

NCT00572520

Depression Obesity

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To examine physiological and behavioral factors that may help determine health in perimenopausal middle age women. Neuroendocrine function will be measured by broad assessment of hypothalamic-pituitary-adrenal (HPA) activity. We will also assess metabolic profiles and behavioral and emotional function. We plan to determine correlations between these measures and nutritional state. Other measures may include insulin, glucose, leptin, IGF-1, triglycerides, free fatty acids, and ghrelin and eating attitudes and physical reactivity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Body Weight

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Body Mass index 18-39.9 kg/m2
* Peri-menopausal status by self-report

Exclusion Criteria

* Pregnant
* Plan to become pregnant
* Breastfeeding in the last 6 months
* Multiple sclerosis, amyotrophic lateral sclerosis, Parkinson's disease
* Menopause confirmed
* Unable to refrain from smoking for five hours (self-report)
* Unable to refrain from consuming alcohol for two days (self-report)
* Weight change \> 10 lbs in the preceding 6 months
* Chronic corticosteroid use
* Oral corticosteroids used more than twice in the last 12 months
* Hormonal contraceptives
* Antipsychotic, anti-anxiety and anti-depressant medications
* Beta adrenergic blockers
* Sibutramine, orlistat, phentermine, phendimetrazine, topiramate, zonisamide
* Immunosuppressants
* Amphetamines and other stimulants
* Severe food allergies or intolerances to foods
* Insulin Dependent Diabetes Mellitus

Minimum Eligible Age

42 Years

Maximum Eligible Age

52 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes